These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15146024)

  • 1. Pre-treatment with corticosteroids and a single cycle of high dose albendazole for subarachnoidal cysticercosis.
    Márquez-Caraveo C; Góngora-Rivera F; Santos Zambrano J; Hernández R; Soto-Hernández JL
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):938-9. PubMed ID: 15146024
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative assessment of lesion load and efficacy of 3 cycles of albendazole in disseminated cysticercosis: a prospective evaluation.
    Pandey S; Malhotra HS; Garg RK; Malhotra KP; Kumar N; Rizvi I; Jain A; Kohli N; Verma R; Sharma P; Uniyal R; Pandey S
    BMC Infect Dis; 2020 Mar; 20(1):220. PubMed ID: 32171260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
    Romo ML; Carpio A; Kelvin EA
    J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.
    Keiser PB; Nash TE
    Clin Infect Dis; 2003 May; 36(10):e122-6. PubMed ID: 12746791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug treatment of neurocysticercosis.
    Garg RK
    Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramedullary Neurocysticercosis Successfully Treated with Medical Therapy.
    Yadav K; Garg D; Kaushik JS; Vaswani ND; Dubey R; Agarwal S
    Indian J Pediatr; 2017 Sep; 84(9):725-726. PubMed ID: 28466406
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurocysticercosis: optimal dose treatment with albendazole.
    Cruz I; Cruz ME; Carrasco F; Horton J
    J Neurol Sci; 1995 Nov; 133(1-2):152-4. PubMed ID: 8583218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.
    García HH; Del Brutto OH
    Neurology; 1999 Oct; 53(7):1582-4. PubMed ID: 10534273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.
    Göngora-Rivera F; Soto-Hernández JL; González Esquivel D; Cook HJ; Márquez-Caraveo C; Hernández Dávila R; Santos-Zambrano J
    Neurology; 2006 Feb; 66(3):436-8. PubMed ID: 16382035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ecuadorian immigrant with headache].
    Ortega-Herrera R; Fernández-Segura ME; Gómez de Travecedo Y Calvo I
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):248-9. PubMed ID: 15056443
    [No Abstract]   [Full Text] [Related]  

  • 11. Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.
    Takayanagui OM; Bonato PS; Dreossi SA; Lanchote VL
    Br J Clin Pharmacol; 2002 Aug; 54(2):125-30. PubMed ID: 12207631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple LC-MS/MS method to determine plasma and cerebrospinal fluid levels of albendazole metabolites (albendazole sulfoxide and albendazole sulfone) in patients with neurocysticercosis.
    González-Hernández I; Ruiz-Olmedo MI; Cárdenas G; Jung-Cook H
    Biomed Chromatogr; 2012 Feb; 26(2):267-72. PubMed ID: 21721022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.
    Cárdenas G; Carrillo-Mezo R; Jung H; Sciutto E; Hernandez JL; Fleury A
    BMC Neurol; 2010 Mar; 10():16. PubMed ID: 20202200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of neurocysticercosis.
    Garg RK
    Neurol India; 2001 Dec; 49(4):329-37. PubMed ID: 11799403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albendazole and Corticosteroids for the Treatment of Solitary Cysticercus Granuloma: A Network Meta-analysis.
    Zhao BC; Jiang HY; Ma WY; Jin DD; Li HM; Lu H; Nakajima H; Huang TY; Sun KY; Chen SL; Chen KB
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004418. PubMed ID: 26849048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant steroid and albendazole for treating neurocysticercosis.
    Shahid SK; Singhi PD
    Indian Pediatr; 1999 Nov; 36(11):1176. PubMed ID: 10745352
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between cysticercosis and epilepsy.
    Monteiro L; Lopes J; Martins da Silva A
    Epilepsia; 1999 Oct; 40(10):1464-5. PubMed ID: 10528946
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
    Jung-Cook H
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short course of albendazole therapy for neurocysticercosis.
    Alarcón F; Maldonado JC
    Clin Neurol Neurosurg; 2006 Dec; 108(8):810-1. PubMed ID: 16647198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.